These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Severe romiplostim-induced rebound thrombocytopenia after splenectomy for refractory ITP. Choe MJ; Packer CD Ann Pharmacother; 2015 Jan; 49(1):140-4. PubMed ID: 25325908 [TBL] [Abstract][Full Text] [Related]
3. First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine - case report. Osmanodja B; Schreiber A; Schrezenmeier E; Seelow E BMC Nephrol; 2021 Dec; 22(1):411. PubMed ID: 34895163 [TBL] [Abstract][Full Text] [Related]
4. [Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination]. Sato K; Anayama M; Sumi M; Kobayashi H Rinsho Ketsueki; 2021; 62(12):1688-1693. PubMed ID: 35022338 [TBL] [Abstract][Full Text] [Related]
5. Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopenia. Ruzicka M; Wurm S; Lindner L; Dreyling M; von Bergwelt-Baildon M; Boeck S; Giessen-Jung C; Milani V; Stemmler JH; Subklewe M; Weigert O; Spiekermann K Infection; 2023 Feb; 51(1):231-238. PubMed ID: 36195695 [TBL] [Abstract][Full Text] [Related]
6. Thrombopoietin receptor agonists in refractory immune thrombocytopenia: differential responses to eltrombopag and romiplostim: a case report and possible explanations. Aoki T; Harada Y; Matsubara E; Suzuki T; Oyama T; Kasai M; Uchida T; Ogura M J Clin Pharm Ther; 2012 Dec; 37(6):729-32. PubMed ID: 22583038 [TBL] [Abstract][Full Text] [Related]
7. Treatment patterns and outcomes of second-line rituximab and thrombopoietin receptor agonists in adult immune thrombocytopenia: A Canadian retrospective cohort study. Podstawka J; Wall E; Bolster L; Patterson JM; Goodyear MD; Rydz N; Sun HL Thromb Res; 2022 Dec; 220():5-11. PubMed ID: 36257098 [TBL] [Abstract][Full Text] [Related]
8. Analysis of hematologic adverse events reported to a national surveillance system following COVID-19 bivalent booster vaccination. Jacobs JW; Booth GS; Adkins BD Ann Hematol; 2023 Apr; 102(4):955-959. PubMed ID: 36795118 [TBL] [Abstract][Full Text] [Related]
9. Successful Treatment of Immune Thrombocytopenic Purpura with Intracranial Hemorrhaging and Duodenal Bleeding Following SARS-CoV-2 Vaccination. Baba Y; Sakai H; Kabasawa N; Harada H Intern Med; 2022 Jun; 61(12):1891-1895. PubMed ID: 35400701 [TBL] [Abstract][Full Text] [Related]
10. Chronic immune thrombocytopenia in a child responding only to thrombopoietin receptor agonist. Osman ME Sudan J Paediatr; 2012; 12(2):60-4. PubMed ID: 27493347 [TBL] [Abstract][Full Text] [Related]
11. Complement activation negatively affects the platelet response to thrombopoietin receptor agonists in patients with immune thrombocytopenia: a prospective cohort study. Åkesson A; Bussel JB; Martin M; Blom AM; Klintman J; Ghanima W; Zetterberg E; Garabet L Platelets; 2023 Dec; 34(1):2159019. PubMed ID: 36636835 [TBL] [Abstract][Full Text] [Related]
12. Successful resection of intrahepatic cholangiocarcinoma with idiopathic thrombocytopenic purpura using thrombopoietin receptor agonist: a case report. Hoshino K; Harimoto N; Muranushi R; Araki K; Yamanaka T; Hagiwara K; Ishii N; Tsukagoshi M; Igarashi T; Tanaka H; Watanabe A; Kubo N; Yokobori T; Shirabe K Surg Case Rep; 2019 Apr; 5(1):56. PubMed ID: 30969381 [TBL] [Abstract][Full Text] [Related]
13. Severe case of refractory immune thrombocytopenic purpura requiring splenectomy after the COVID-19 vaccine. Koilpillai S; Dominguez B; Khan A; Carlan S BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35725277 [TBL] [Abstract][Full Text] [Related]
14. A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. Kim G; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH J Korean Med Sci; 2021 Nov; 36(43):e306. PubMed ID: 34751013 [TBL] [Abstract][Full Text] [Related]
15. Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study. Al-Samkari H; Jiang D; Gernsheimer T; Liebman H; Lee S; Wojdyla M; Vredenburg M; Cuker A Br J Haematol; 2022 May; 197(3):359-366. PubMed ID: 35179784 [TBL] [Abstract][Full Text] [Related]
17. Successful eltrombopag treatment of severe refractory thrombocytopenia in chronic myelomonocytic leukemia: Two cases reports: A CARE-compliant article. Gao Y; Gong M; Zhang C; Kong X; Ma Y Medicine (Baltimore); 2017 Oct; 96(43):e8337. PubMed ID: 29069007 [TBL] [Abstract][Full Text] [Related]
18. COVID-19-induced immune thrombocytopenia management approach: A case report and literature review. Alahwal HM; Alsharif MH; Alsharif MH; Almohammadi AT; Al-Marzouki AF; Barefah AS; Bahashwan SM; Radhwi OO; Damanhouri GA Clin Case Rep; 2024 Jun; 12(6):e9070. PubMed ID: 38883219 [TBL] [Abstract][Full Text] [Related]
19. Use of romiplostim in a hemodialysis patient with primary immune thrombocytopenia. Al-Jafar H; Giagounidis A; El-Rashaid K; Al-Ali M; Hakim AA Ann Pharmacother; 2012 Nov; 46(11):e31. PubMed ID: 23115229 [TBL] [Abstract][Full Text] [Related]